Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-16 Sale |
2024-12-18 9:00 pm |
Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer |
10,000 | $12.42 | $124,200 | 202,014 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-20 9:31 pm |
Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer |
7,246 | $10.78 | $78,112 | 109,885 (Direct) |
View |
| 2024-11-18 Sale |
2024-11-20 9:30 pm |
Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer |
5,207 | $10.78 | $56,131 | 87,045 (Direct) |
View |
| 2024-08-16 Sale |
2024-08-19 8:00 pm |
Replimune Group Inc. | REPL | Hill Emily Luisa Chief Financial Officer |
8,938 | $10.18 | $90,989 | 101,057 (Direct) |
View |
| 2024-06-07 Sale |
2024-06-10 8:30 pm |
Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer |
15,881 | $7.5 | $119,108 | 117,131 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-20 8:06 pm |
Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer |
2,218 | $6.47 | $14,350 | 92,252 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-20 8:06 pm |
Replimune Group Inc. | REPL | Schwendenman Andrew Chief Accounting Officer |
2,298 | $6.47 | $14,868 | 38,238 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-20 8:05 pm |
Replimune Group Inc. | REPL | Love Colin Chief Operating Officer |
17,615 | $6.47 | $113,969 | 777,345 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-20 8:04 pm |
Replimune Group Inc. | REPL | Astley-Sparke Philip Executive Chairman |
37,928 | $6.47 | $245,394 | 1,487,350 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-20 8:02 pm |
Replimune Group Inc. | REPL | Coffin Robert Director |
11,464 | $6.47 | $74,172 | 1,821,872 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-20 8:01 pm |
Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer |
20,194 | $6.47 | $130,655 | 212,014 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-20 8:00 pm |
Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer |
6,367 | $6.47 | $41,194 | 133,012 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-04-01 Option Award |
2025-04-03 8:06 pm |
N/A 2035-04-01 |
Replimune Group Inc. | REPL | Peeples-Dyer Veleka Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 8:06 pm |
N/A 2035-04-01 |
Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer |
416,667 | $0 | 618,681 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 8:05 pm |
N/A 2035-04-01 |
Replimune Group Inc. | REPL | Pucci Paolo Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 8:05 pm |
N/A 2035-04-01 |
Replimune Group Inc. | REPL | Balachandran Madhavan Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 8:04 pm |
N/A 2035-04-01 |
Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer |
112,500 | $0 | 222,385 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 8:03 pm |
N/A 2035-04-01 |
Replimune Group Inc. | REPL | Dhingra Kapil Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 8:02 pm |
N/A 2035-04-01 |
Replimune Group Inc. | REPL | SLATTERY JOSEPH P Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 8:02 pm |
N/A 2035-04-01 |
Replimune Group Inc. | REPL | Hill Emily Luisa Chief Financial Officer |
112,500 | $0 | 213,557 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 8:01 pm |
N/A 2035-04-01 |
Replimune Group Inc. | REPL | Weinand Dieter Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 8:01 pm |
N/A 2035-04-01 |
Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer |
112,500 | $0 | 199,545 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 8:00 pm |
N/A 2035-04-01 |
Replimune Group Inc. | REPL | Oliger Christy J. Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2025-04-01 Option Award |
2025-04-03 8:00 pm |
N/A 2035-04-01 |
Replimune Group Inc. | REPL | Schwendenman Andrew Chief Accounting Officer |
83,333 | $0 | 121,571 (Direct) |
View |
| 2025-03-05 Option Award |
2025-03-07 4:55 pm |
N/A 2035-03-05 |
Replimune Group Inc. | REPL | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
128,000 | $0 | 128,000 (Indirect) |
View |
Ownership |
2025-03-07 4:52 pm |
N/A N/A |
Replimune Group Inc. | REPL | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner |
0 | $0 | 25,103,489 (Indirect) |
View |
| 2024-09-04 Option Award |
2024-09-05 8:10 pm |
N/A 2034-09-04 |
Replimune Group Inc. | REPL | Balachandran Madhavan Director |
64,000 | $0 | 64,000 (Direct) |
View |
| 2024-08-30 Gift |
2024-08-30 8:00 pm |
N/A N/A |
Replimune Group Inc. | REPL | Astley-Sparke Philip Executive Chairman |
50,000 | $0 | 1,437,350 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 8:04 pm |
N/A 2034-04-01 |
Replimune Group Inc. | REPL | Peeples-Dyer Veleka Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 8:03 pm |
N/A 2034-04-01 |
Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer |
333,335 | $0 | 482,208 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 8:02 pm |
N/A 2034-04-01 |
Replimune Group Inc. | REPL | Pucci Paolo Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 8:02 pm |
N/A 2034-04-01 |
Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer |
106,665 | $0 | 219,379 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 8:01 pm |
N/A 2034-04-01 |
Replimune Group Inc. | REPL | Dhingra Kapil Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 8:01 pm |
N/A 2034-04-01 |
Replimune Group Inc. | REPL | Hill Emily Luisa Chief Financial Officer |
106,665 | $0 | 189,995 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 8:01 pm |
N/A 2034-04-01 |
Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer |
88,900 | $0 | 161,145 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 8:01 pm |
N/A 2034-04-01 |
Replimune Group Inc. | REPL | SLATTERY JOSEPH P Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 8:00 pm |
N/A 2034-04-01 |
Replimune Group Inc. | REPL | Weinand Dieter Director |
32,000 | $0 | 32,000 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 8:00 pm |
N/A 2034-04-01 |
Replimune Group Inc. | REPL | Oliger Christy J. Director |
32,000 | $0 | 32,000 (Direct) |
View |